Nationwide Fund Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-7,245
Closed -$38K 3283
2017
Q1
$38K Hold
7,245
﹤0.01% 3027
2016
Q4
$34K Hold
7,245
﹤0.01% 3050
2016
Q3
$48K Hold
7,245
﹤0.01% 3052
2016
Q2
$40K Hold
7,245
﹤0.01% 3106
2016
Q1
$155K Buy
7,245
+11
+0.2% +$235 ﹤0.01% 2642
2015
Q4
$229K Buy
7,234
+591
+9% +$18.7K ﹤0.01% 2480
2015
Q3
$229K Buy
6,643
+220
+3% +$7.58K ﹤0.01% 2493
2015
Q2
$202K Buy
6,423
+967
+18% +$30.4K ﹤0.01% 2705
2015
Q1
$160K Buy
5,456
+73
+1% +$2.14K ﹤0.01% 2802
2014
Q4
$100K Buy
5,383
+118
+2% +$2.19K ﹤0.01% 2906
2014
Q3
$92K Sell
5,265
-5
-0.1% -$87 ﹤0.01% 3013
2014
Q2
$105K Buy
+5,270
New +$105K ﹤0.01% 3012